Exercise Before Melanoma Immunotherapy Treatment
Part of Cancer, Skin clinical trials.
This study tests whether doing physical exercise right before receiving immunotherapy (two drugs called nivolumab and ipilimumab) helps treat advanced melanoma. The goal is to see if exercise boosts how well these cancer-fighting drugs work in your body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with metastatic melanoma (cancer that has spread) confirmed by biopsy
- Your doctor has recommended nivolumab and ipilimumab as your first systemic cancer treatment
- Age 18 or older and able to provide written consent
- Good enough health to exercise (ECOG score of 2 or better—able to care for yourself most of the time)
- No major surgery in the past 2 weeks
- Not currently on high-dose steroids or other immune-suppressing medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well immunotherapy drugs like pembrolizumab and nivolumab work for people with advanced melanoma that has spread. It aims to find markers that predict treatment response.
This study tests whether adding high-intensity exercise and a high-fiber diet can improve how well immunotherapy works for people with melanoma. It might help you if you are already on immunotherapy and are not currently very active or eating a lot of fiber.
This study looks at whether physical activity can help reduce side effects from immunotherapy in people with melanoma. You may join if you are starting a certain type of immunotherapy for melanoma.
This trial looks at whether adding a program of exercise and nutrition changes can improve quality of life and treatment outcomes for people with melanoma who are starting immunotherapy. If you qualify, you would take part in a structured plan to see if these lifestyle changes help.
This trial tests if a supervised exercise program can help reduce symptoms like fatigue and improve well-being in people with advanced melanoma who are already on immunotherapy or targeted therapy. You would visit the study hospital for training sessions and check-ups.
This trial tests if a moderate-intensity exercise program helps adults with melanoma who are receiving chemotherapy before surgery. It aims to improve recovery and well-being during treatment.
Hear when a new Metastatic Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.